Page 242 - book

Dosage
Type Product Strengh Indication Status
Form

Act./Phe./Chol. Tablet 325/ 5/ 2 mg Cold And Flu Symptoms Active
Analge- sics

Mefenamic Acid Capsule 250 mg Pain Active

Duodenal Ulcer-Gastric Ulcer
Famotidine Tablet 20 & 40 mg Active
-GERD-Heartburn

Duodenal Ulcer Associated
Bismuth Subcitrate Tablet 120 mg With Helicobacter Pylori Active IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Infection

Gastrointestinal/ Genitouri-
Hyoscine Butyl Bromide Tablet 10 mg Active
nary Spasm
Duodenal Ulcer-Gastric Ul-
Omeprazole Capsule 20 mg Active
cer-GERD-Erosive Esophagitis

Peptic Ulcer-Helicobacter Py-
lori Eradication-GERD-Erosive
Esomeprazole Capsule 20 & 40 mg Esophagitis Prevention And Active
Treatment Of NSAID-Induced
Gastric Ulcers

Peptic Ulcer-Helicobacter Py-
lori Eradication-GERD- Erosive
D.R. Cap-
Lansoprazole 15 & 30 mg Esophagitis Prevention And Active
sule
Treatment Of NSAID-Induced
Gastric Ulcers
Gastrointestinal Agents Pantoprazole D.R.Cap- 20 & 40 mg With GERD-Pathological Hyper- Active
Erosive Esophagitis Associated
sule
secretory Conditions, Including
Zollinger-Ellison Syndrome

Erosive Esophagitis Associated
With GERD-Pathological Hyper-
20 & 40 mg
Pantoprazole
D.R.Tablet
secretory Conditions, Including
Zollinger-Ellison Syndrome Active
Gastrointestinal/Genitourinary
Mebeverine Tablet 135 mg Spasm Active

E.R. Cap- Gastrointestinal/Genitourinary
Mebeverine 200 mg Active
sule Spasm
Emotional And Somatic
Clidinium/chlordiazep- Tablet 2.5/5 mg Factors In Gastrointestinal Active
oxide Disorders-Irritable Bowel Syn-
drome-Peptic Ulcer

Prevention Of Chemothera-
py-Induced Nausea And Vom-
Aprepitant Capsule 80 & 125 mg iting-Prevention Of Postop- Active
erative Nausea And Vomiting
(PONV)

Mesalazine E.R.Tablet 250 & 500 mg Crohn Disease- Ulcerative Active
Colitis
250 & 400 & Crohn Disease- Ulcerative
Mesalazine D.R.Tablet Active
500 & 800 mg Colitis 241